You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A2A receptor blockade for sepsis

    SBC: Purine Pharmaceuticals Inc.            Topic: NIAID

    SUMMARY Sepsis is a clinical syndrome that complicates severe infectionSepsis remains the leading cause of morbidity and mortality in critically ill patientsThere are no specific FDA approved medicines for the treatment of sepsisCurrent concepts of the pathophysiology of sepsis suggest that organ failure and mortality in sepsis are caused by inappropriate regulation of the immune systemThis manife ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  2. A2B receptor stimulation for sepsis

    SBC: Purine Pharmaceuticals Inc.            Topic: NIAID

    SUMMARYSepsis is a medical condition caused by an overwhelming systemic inflammatory response to infection. Although the underlying infection can now be efficiently treated with antibiotics, there are no effective therapies to control the organ damage caused by the inflammatory response of the host. As a result, sepsis is the leading cause of mortality in intensive care units and is the tenth lead ...

    STTR Phase I 2022 Department of Health and Human ServicesNational Institutes of Health
  3. AC5 Inhibitor for Obesity

    SBC: VASADE BIOSCIENCES, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): The goal of this proposal is to develop a drug that will be therapeutic for obesity and diabetes and improve exercise tolerance. Obesity, diabetes and exercise are inextricably linked such that an agent that improves exercise tolerance or prevents obesity or the development of diabetes will likely have a therapeutic role in all three conditions. Obesity is a gl ...

    STTR Phase I 2010 Department of Health and Human ServicesNational Institutes of Health
  4. Adaptable Tactical Communications

    SBC: ASPEN CONSULTING GROUP INC            Topic: A19CT005

    Army tactical operations frequently occur in congested and contested RF spectral conditions, which can impair a system's ability to transmit information over wireless networks. Whether the source of impairment is due to ordinary congestion in the spectrum, malicious jamming, propagation conditions or natural/man-made interference, identifying the source of the impairment is an important step in ad ...

    STTR Phase I 2020 Department of DefenseArmy
  5. Adaptable Tactical Communications

    SBC: ASPEN CONSULTING GROUP INC            Topic: A19CT005

    Army tactical operations frequently occur in congested and contested RF spectral conditions, which can impair a system's ability to transmit information over wireless networks. Whether the source of impairment is due to ordinary congestion in the spectrum, malicious jamming, propagation conditions or natural/man-made interference, identifying the source of the impairment is an important step in ad ...

    STTR Phase II 2021 Department of DefenseArmy
  6. Advanced Absorbance Detection for the AUC

    SBC: AVIV BIOMEDICAL INC            Topic: N/A

    DESCRIPTION (provided by applicant): The purpose of this STTR is to produce a commercially available rapid-scan absorbance optical detection system for XLA/I analytical ultracentrifuges. The currently available absorbance optical system provided by the analytical ultracentrifuge manufacturer is not optimized for sedimentation velocity analysis, the most commonly used analytical ultracentrifugation ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  7. Advanced Cannula Development for Coronary Sinus Access

    SBC: STRATEGIC PACING SYSTEMS LLC            Topic: NHLBI

    DESCRIPTION provided by applicant This Phase STTR will develop novel techniques for coronary sinus access The coronary sinus provides unique anatomic and physiologic proximity to all four cardiac chambers and the coronary circulation For example the coronary sinus is used for left ventricular lead insertion for biventricular pacing or cardiac resynchronization Mor than such implan ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Advanced Electrolytes for Safe, High Voltage, High Energy Cells

    SBC: LITHIUM BATTERY ENGINEERING Limited Liability Company            Topic: A21CT016

    The specific objective of this STTR is to develop a high energy dense, safe, rechargeable Li battery by replacing the conventional flammable carbonate-based electrolyte with a solid state electrolyte and/or ionic liquid.  This proposal focuses on developing a > 350 Wh/kg cell with an average discharge voltage of >4.6 V and retaining > 80% capacity over 100 cycles, using a room temperature ionic l ...

    STTR Phase I 2022 Department of DefenseArmy
  9. Advanced Metal Anodes for Lithium Metal Secondary Batteries

    SBC: LiBAMA            Topic: A18BT015

    Lithium metal represents the ultimate anode material due to its high energy density (3860 mAh/g), however, dendrite growth during charge has been essentially preventing its wide application in rechargeable batteries. LiBAMA's bi-functional advanced metal anode (AMA) represents the world's first innovation evolved out of numerous failed and on-going efforts with solid electrolytes, lithium protecti ...

    STTR Phase I 2019 Department of DefenseArmy
  10. Affordable, UV-, heat- and water-resistant radiochromic film composed of diacetylenes having chromophoric groups

    SBC: JP LABORATORIES INC            Topic: 300

    Project Summary: Self-developing, instant radiochromic films based on the solid-state polymerization of diacetylenes (R-C≡C-C≡C- R’, where R and R’ are substituent groups) are used for measuring radiation therapy dose. Currently available radiochromic films, e.g., the GafChromicTM EBT films from Ashland (Bridgewater, NJ, USA), have many drawbacks such as they are very expensive, sensitive ...

    STTR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government